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INTRODUCTION
Acute myocardial infarction (AMI) is caused by
thrombus formation over a disrupted plaque occluding
an epicardial coronary artery. The strategies to reper-
fuse an occluded coronary artery in the setting of AMI
are either pharmacological (eg, fibrinolysis) or mechan-
ical such as primary percutaneous coronary interven-
tion (PCI). A great deal of evidence indicates that expe-
ditious restoration of flow in the obstructed infarct
artery after the onset of symptoms in ST Elevation My-
ocardial Infarction (STEMI) patients is a key determinant
of short- and long-term outcomes, regardless of
whether reperfusion is accomplished by fibrinolysis or
PCI (1-3). However, even after successful recanalization
of the occluded artery, with consequent restoration of
epicardial flow, distal perfusion at the tissue level may
become impaired (i.e., “no-reflow”), secondary to impair-
ment of microcirculation (4). This phenomenon is particu-
larly relevant when a heavy thrombus burden is present in
the artery lumen, as may happen in particular circum-
stances like mechanical recanalization of saphenous vein
grafts or coronary artery aneurysm due to the possibility
of distal embolization of thrombus material (5). So the ra-
tionale for mechanical thrombectomy in removing throm-
bus burden from IRA is to minimize embolization.
Here we report a case of an aneurysmatic dilatation
of an infarct-related artery (IRA) referred to our Institute
for rescue PCI after failed fibrinolysis, successfully
treated with only rheolytic thrombectomy (AngioJet,
Possis Medical, Minneapolis, Minnesota, USA), without
the need for adjunctive balloon or stent implantation.
CASE REPORT
A 68-year-old man was admitted to our coronary care
unit (CCU) for acute myocardial infarction. ECG re-
vealed ST-segment elevation in leads II, III, aVF. Intra-
venous fibrinolysis with TNK-tPA and adjunctive an-
tithrombotic and antiplatelet therapy with heparin and
aspirin respectively, was initiated as soon as he arrived
in CCU. Time from onset symptoms to lysis therapy was
one hour and 20 minutes. Because of the persistence of
ST-segment elevation and chest pain 90 minutes after
thrombolytic therapy, he underwent coronary angiogra-
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phy by transradial approaches that revealed acute
thrombotic occlusion of the left circumflex coronary
(LCx) artery at the proximal tract (TIMI 0) with aneurys-
mal dilatation, fusiform type, (Fig. 1) and 80% stenosis
of the mid segment of the left anterior descending (LAD)
coronary artery; no significant stenosis were seen in the
right coronary artery. Activated clotting time (ACT) was
out of range, so no adjunctive unfractioned heparin or
glycoprotein IIb/IIIa inhibitors could be administered.
The left coronary artery was then selectively engaged
with a 6Fr guiding catheter (Amplatz 1, Cordis, Johnson
& Johnson, Miami, FL, USA) by transradial approaches
too. A guidewire (ACS HI-Torque Intermediate 0.014’’,
Guidant, Indianapolis, IN, USA) was crossed through
the occlusion; the angiogram showed a TIMI 0 flow. Be-
cause of the image of heavy thrombus contained in the
coronary aneurysm we decided to remove it by the rhe-
olytic thrombectomy system 4Fr monorail catheter (An-
gioJet, Possis Medical, Minneapolis, Minnesota, USA).
The rheolytic thrombectomy system AngioJet re-
moves thrombi via rheolytic fragmentation and simulta-
neous active removal through hydrostatic suction. The
catheter is attached to a drive unit with a piston pump
that generates a high-pressure pulsed flow rate of
10,000 psi at 60cc/min through a hypotube. The hypo-
tube ejects saline at a loop in the catheter tip. The jets
of high-velocity saline are directed back into an exhaust
lumen. This creates a vortex (Venturi effect) that frag-
ments and aspirates thrombus and loose debris. The
vortex is centered at side holes within the catheter to
drive the aspiration of thrombus. Rheolytic thrombecto-
my was successful, with a final TIMI grade 3 flow and
ST-segment resolution without the need for balloon or
stent (Fig. 2). No temporary pacemaker is needed dur-
ing rheolytic thrombectomy with AngioJet. The patient
returned to the CCU in stable condition asymptomatic.
Peak concentration of CK, MB fraction and Troponin I
reached 4418 UI/L, 242.8 ng/mL and 177 ng/mL re-
spectively. Blood chemistry was otherwise normal. The
patient was discharged in good condition after five
days, with oral anticoagulation therapy, and remains
free of major adverse cardiac events at 30 days.
DISCUSSION
Coronary artery aneurysms are classified as either
saccular or fusiform type. Coronary aneurysm can
Fig. 1 - LCx before primary PCI. The arrow indicates the coronary
aneurysm and the presence of thrombus.
Fig. 2 - LCx after rheolytic thrombectomy with AngioJet; note the
complete absence of image suggesting the presence of a throm-
bus in the coronary aneurysm.AngioJet thrombectomy and coronary aneurysm
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cause angina pectoris or AMI. In one study, 2.6% of pa-
tients undergoing primary PCI was found to have a
coronary aneurysm in the IRA (6). Aneurysmal dilatation
of an IRA is associated with high-burden thrombus for-
mation and a lower incidence of successful pharmaco-
logical or mechanical reperfusion (7, 8). PCI-treated pa-
tients experience lower short-term mortality rates, less
nonfatal reinfarction, and less hemorrhagic stroke than
those treated by fibrinolysis (9). However, PCI and
stenting carry the risk of mobilizing thrombotic and
thrombogenic material, causing distal embolization and
microcirculatory impairment, which may limit myocar-
dial salvage achieved by these techniques. In the set-
ting of AMI the presence of coronary aneurysm of the
IRA filled with heavy thrombus represent a challenge
case for the interventional cardiologist. In fact the pres-
ence of thrombus predispose PCI to a high rate of
thrombus embolization and no-reflow phenomenon. Al-
so a pharmacological approach such as glycoprotein
IIb/IIIa inhibitors could be dangerous after lysis and
when a high degree of ACT is present. Direct stenting
without predilation may decrease embolization and the
incidence of the no-reflow phenomenon (10). More spe-
cific approaches to the problem of microvessel em-
bolization during PCI include thrombectomy by different
techniques and the use of anti-embolic protection de-
vices. However distal embolization filter are not suitable
for all coronary artery anatomy. Two randomized trials
have reported rheolytic thrombectomy with AngioJet to
be effective in decreasing embolization in patients who
underwent PCI on venous grafts or native coronary ves-
sel with massive thrombosis (11, 12). Only one case re-
port described the use of the AngioJet rheolytic
thrombectomy device in a coronary aneurysm, but with
the subsequent implantation of a JoStent coronary
artery graft (13). Fibrinolysis or primary PCI have a high
degree of failure in the treatment of coronary aneurysm
in AMI (7,8). So the rheolytic thrombectomy system An-
gioJet represents a novel, extraordinary and useful tool
also to treat this complicated and rare case in which
there is a high degree of thrombus burden. AngioJet had
an excellent pushability and trackability also in tortur-
ous coronary artery and in the mid and distal tract of the
LCx: this device may allow removal of soft material im-
mediately before PCI or stenting to avoid or minimize
distal embolization. Initial thrombus removal also per-
mits early identification of lesion characteristics and
more site-specific treatment of the underlying culprit le-
sion, particularly in patients with total occlusion. To our
knowledge, this is the first report of the use of the An-
gioJet rheolytic trombectomy in a coronary aneurysm,
as the culprit lesion in the setting of AMI, without the
need for subsequent use of balloon or stent implanta-
tion.
CONCLUSION
The presence of coronary aneurysm of the IRA is a
quite rare situation. The presence of a high grade of
thrombus in the coronary aneurysm during AMI, predis-
pose PCI to a high rate of thrombus embolization, no-re-
flow phenomenon and failure. The rheolytic thrombecto-
my system AngioJet is a very useful tool and may be a
novel approach to reperfuse coronary aneurysms during
PCI also in these difficult and rare circumstances to war-
rant a high rate of complete reperfusion.
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